In some types of cancer, such as glioblastoma, renal-cell carcinoma, lung cancer, colon adenocarcinoma, and hepatocellular carcinoma, among others, PD-L1 has been associated with a poor prognosis. Here, CD274 is linked to lung carcinoma.